NEXORA PEPTIDES
← Back to library
NEXORA Retatrutide 20 mg research vial

Investigational metabolic peptide

Retatrutide

Retatrutide (LY3437943)

An investigational triple-receptor agonist studied in clinical research.

Research specification

20 mg per vial

Private quote available

For Research Purposes Only

Request a Quote

Product research overview

Retatrutide is under clinical investigation for metabolic indications.

Research starting points